Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Mutations (EGFR-m) and Breast Cancer (BC): A Retrospective Analysis

被引：0
|
作者：
Moran, Teresa [1 ]
Quiroga, Vanesa [1 ]
Carcereny, Enric [1 ]
Cirauqui, Beatriz [1 ]
Margeli, Mireia [1 ]
Vila, Laia [1 ]
De Los, Maria [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
EGFR mutations; Breast Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI13.13
引用
收藏
页码：S310 / S311
页数：2
相关论文
共 50 条
  • [1] Non-Small Cell Lung Cancer (NSCLC) harboring Epidermal Growth Factor Receptor mutations (EGFR-m) and breast cancer (BC): A retrospective analysis of a single institution.
    Moran, Teresa
    Quiroga, Vanesa
    Carcereny Costa, Enric
    Cirauqui, Beatriz
    Margeli, Mireia
    VilA Martinez, Laia
    Gil Moreno, Maria de los Llanos Gil
    Indacochea, Alberto
    Cuadra Urteaga, Jose Luis
    Queralt, Cristina
    de Aguirre, Itziar
    Luis Ramirez, Jose
    Castella, Eva
    Lopez, Yessica
    Luis Mate, Jose
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Postoperative management for non-small cell lung cancer harboring EGFR mutations
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4556 - 4560
  • [3] EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations
    Tang, Wenjie
    Li, Xiaolin
    Xi, Xueqi
    Sun, Xindong
    Liu, Jie
    Zhang, Jian
    Wang, Chungang
    Yu, Jinming
    Xie, Peng
    LUNG CANCER, 2019, 136 : 6 - 14
  • [4] Efficacy of EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients Harboring Different Types of EGFR Mutations:A Retrospective Analysis
    刘华丽
    韩光
    彭敏
    翁一鸣
    袁静萍
    杨桂芳
    于金明
    宋启斌
    Current Medical Science, 2017, 37 (06) : 864 - 872
  • [5] Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis
    Liu, Hua-li
    Han, Guang
    Peng, Min
    Weng, Yi-ming
    Yuan, Jing-ping
    Yang, Gui-fang
    Yu, Jin-ming
    Song, Qi-bin
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (06) : 864 - 872
  • [6] Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis
    Hua-li Liu
    Guang Han
    Min Peng
    Yi-ming Weng
    Jing-ping Yuan
    Gui-fang Yang
    Jin-ming Yu
    Qi-bin Song
    Current Medical Science, 2017, 37 : 864 - 872
  • [7] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [8] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [9] Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
    Heigener, David F.
    Schumann, Christian
    Sebastian, Martin
    Sadjadian, Parvis
    Stehle, Ingo
    Maerten, Angela
    Lueers, Anne
    Griesinger, Frank
    Scheffler, Matthias
    ONCOLOGIST, 2015, 20 (10): : 1167 - 1174
  • [10] Acquired EGFR-resistant mutations in non-small cell lung cancer (NSCLC).
    Raez, Luis E.
    Baca, Yasmine
    Nieva, Jorge J.
    Mamdani, Hirva
    Lopes, Gilberto
    Borghaei, Hossein
    Socinski, Mark A.
    Nabhan, Chadi
    Wozniak, Antoinette J.
    Vanderwalde, Ari M.
    Uribe, Carlos Carracedo
    Khan, Hina
    Liu, Stephen V.
    Nagasaka, Misako
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345